Suarez S - Search Results

1

Nanoengineering of therapeutics for retinal vascular disease.

Gahlaut N, Suarez S, Uddin MI, Gordon AY, Evans SM, Jayagopal A. Gahlaut N, et al. Among authors: suarez s. Eur J Pharm Biopharm. 2015 Sep;95(Pt B):323-30. doi: 10.1016/j.ejpb.2015.05.001. Epub 2015 May 28. Eur J Pharm Biopharm. 2015. PMID: 26022642 Free PMC article. Review.

2

High Glucose-induced Retinal Pericyte Apoptosis Depends on Association of GAPDH and Siah1.

Suarez S, McCollum GW, Jayagopal A, Penn JS. Suarez S, et al. J Biol Chem. 2015 Nov 20;290(47):28311-28320. doi: 10.1074/jbc.M115.682385. Epub 2015 Oct 5. J Biol Chem. 2015. PMID: 26438826 Free PMC article.

3

Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.

Barnett JM, Suarez S, McCollum GW, Penn JS. Barnett JM, et al. Among authors: suarez s. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(10):6490-8. doi: 10.1167/iovs.14-14945. Invest Ophthalmol Vis Sci. 2014. PMID: 25159209 Free PMC article.

4

Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.

Suarez S, McCollum GW, Bretz CA, Yang R, Capozzi ME, Penn JS. Suarez S, et al. Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):8232-40. doi: 10.1167/iovs.14-14217. Invest Ophthalmol Vis Sci. 2014. PMID: 25406289 Free PMC article.

5

NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.

Bretz CA, Savage SR, Capozzi ME, Suarez S, Penn JS. Bretz CA, et al. Among authors: suarez s. Sci Rep. 2015 Nov 3;5:14963. doi: 10.1038/srep14963. Sci Rep. 2015. PMID: 26527057 Free PMC article.

6

Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility.

Gay B, Suarez S, Weber C, Rahuel J, Fabbro D, Furet P, Caravatti G, Schoepfer J. Gay B, et al. Among authors: suarez s. J Biol Chem. 1999 Aug 13;274(33):23311-5. doi: 10.1074/jbc.274.33.23311. J Biol Chem. 1999. PMID: 10438507 Free article.

7

VEGF transiently disrupts gap junctional communication in endothelial cells.

Suarez S, Ballmer-Hofer K. Suarez S, et al. J Cell Sci. 2001 Mar;114(Pt 6):1229-35. doi: 10.1242/jcs.114.6.1229. J Cell Sci. 2001. PMID: 11228166

8

Selective GRB2 SH2 inhibitors as anti-Ras therapy.

Gay B, Suarez S, Caravatti G, Furet P, Meyer T, Schoepfer J. Gay B, et al. Among authors: suarez s. Int J Cancer. 1999 Oct 8;83(2):235-41. doi: 10.1002/(sici)1097-0215(19991008)83:2<235::aid-ijc15>3.0.co;2-b. Int J Cancer. 1999. PMID: 10471533 Free article.

9

Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs.

Scheidegger P, Weiglhofer W, Suarez S, Kaser-Hotz B, Steiner R, Ballmer-Hofer K, Jaussi R. Scheidegger P, et al. Among authors: suarez s. Biol Chem. 1999 Dec;380(12):1449-54. doi: 10.1515/BC.1999.187. Biol Chem. 1999. PMID: 10661874

10

Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.

Scheidegger P, Weiglhofer W, Suarez S, Console S, Waltenberger J, Pepper MS, Jaussi R, Ballmer-Hofer K. Scheidegger P, et al. Among authors: suarez s. Biochem J. 2001 Feb 1;353(Pt 3):569-78. doi: 10.1042/0264-6021:3530569. Biochem J. 2001. PMID: 11171054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page